Sep 1, 2016
If you are a business development professional, at some point in your career, it is very likely that you will be asked to organize and lead a sell-side strategic partnering process consistent with your company’s strategy and business development objectives. Having...
Aug 25, 2016
The foundation of any transaction is a negotiation between a buyer and seller around the fair value of an asset. The key to maximizing value in any transaction as a seller or buyer is a robust understanding of an asset’s underlying value. A valuation model is a...
Jul 25, 2016
Many Japanese pharmaceutical companies are now “global” in terms of scope and size. Companies like Takeda, Astellas, and Daiichi Sankyo have established their commercial footprint around the world. Accordingly, the business development teams at these companies are...
Jul 14, 2016
When a company decides to seek a strategic development or commercial partner for an asset, the first inclination is often to identify the likely buyers and begin conversations about a potential deal. However, entering a deal process without first having a full...
Apr 12, 2016
When traditional biotech companies advance through the clinic towards the market, often there is an interest in acquiring a revenue stage product to jumpstart the commercial infrastructure. A module in our next Locust Walk Institute on May 4th and 5th will cover an...
